Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma

被引：33

作者：

Valcamonico, Francesca ^{[1
]}

Ferrari, Vittorio ^{[1
]}

Amoroso, Vito ^{[1
]}

Rangoni, Giovanni ^{[1
]}

Simoncini, Edda ^{[1
]}

Marpicati, Patrizia ^{[1
]}

Vassalli, Lucia ^{[1
]}

Grisanti, Salvatore ^{[1
]}

Marini, Giovanni ^{[1
]}

机构：

[1] Spedali Civili Brescia, Dept Med Oncol, Brescia, Italy

来源：

JOURNAL OF NEURO-ONCOLOGY | 2009年 / 91卷 / 01期

关键词：

Advanced renal cell carcinoma; Sorafenib; Brain metastases; ANTITUMOR-ACTIVITY; TRIAL;

D O I：

10.1007/s11060-008-9676-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

We report the case of a 75-year old woman who received sorafenib (Nexavar (R), Bayer Pharmaceuticals Corporation, West Haven, CT) for a CNS relapse of clear cell renal cell carcinoma. After four months of sorafenib treatment, a brain magnetic resonance imaging showed 95%-volumetric regression of cerebral metastasis. To the best of our knowledge, this is the first almost complete resolution of brain metastases in renal cell carcinoma treated with sorafenib that has been described.

引用

页码：47 / 50

页数：4

共 50 条

[21] Efficacy and safety of advanced renal cell carcinoma patients treated with sorafenib: roles of cytokine pretreatment [J].

Hisanori Suzuki ;

Toshiro Suzuki ;

Osamu Ishizuka ;

Osamu Nishizawa ;

Manabu Ueno .

International Journal of Clinical Oncology, 2014, 19 :686-692

[22] Efficacy and safety of sorafenib in advanced renal cell carcinoma patients: Results from a long-term study [J].

Yang, Lin ;

Shi, Lei ;

Fu, Qiang ;

Xiong, Huihua ;

Zhang, Mengxian ;

Yu, Shiying .

ONCOLOGY LETTERS, 2012, 3 (04) :935-939

[23] Long-term safety of sorafenib in advanced renal cell carcinoma: Follow-up of patients from phase III TARGET [J].

Hutson, Thomas E. ;

Bellmunt, Joaquim ;

Porta, Camillo ;

Szczylik, Cezary ;

Staehler, Michael ;

Nadel, Andrea ;

Anderson, Sibyl ;

Bukowski, Ronald ;

Eisen, Tim ;

Escudier, Bernard .

EUROPEAN JOURNAL OF CANCER, 2010, 46 (13) :2432-2440

[24] Sorafenib rechallenge in patients with metastatic renal cell carcinoma [J].

Nozawa, Masahiro ;

Yamamoto, Yutaka ;

Minami, Takafumi ;

Shimizu, Nobutaka ;

Hatanaka, Yuji ;

Tsuji, Hidenori ;

Uemura, Hirotsugu .

BJU INTERNATIONAL, 2012, 110 (6B) :E228-E234

[25] Microvessel area as a predictor of sorafenib response in metastatic renal cell carcinoma [J].

Saadia A Aziz ;

Joshua A Sznol ;

Laurence Albiges ;

Christopher Zito ;

Lucia B Jilaveanu ;

Robert L Camp ;

Bernard Escudier ;

Harriet M Kluger .

Cancer Cell International, 14

[26] Sequential Therapy With Sorafenib and Sunitinib in Renal Cell Carcinoma [J].

Dudek, Arkadiusz Z. ;

Zolnierek, Jakub ;

Dham, Anu ;

Lindgren, Bruce R. ;

Szczylik, Cezary .

CANCER, 2009, 115 (01) :61-67

[27] A case of advanced renal cell carcinoma with peritoneal carcinomatosis responding to sorafenib therapy [J].

Yao, Akihisa ;

Iwamoto, Hideto ;

Morizane, Shuichi ;

Isoyama, Tadahiro ;

Sejima, Takehiro ;

Takenaka, Atsushi .

INTERNATIONAL CANCER CONFERENCE JOURNAL, 2012, 1 (04) :198-200

[28] A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma [J].

Larkin, J. M. G. ;

Ferguson, T. R. ;

Pickering, L. M. ;

Edmonds, K. ;

James, M. G. ;

Thomas, K. ;

Banerji, U. ;

Berns, B. ;

de Boer, C. ;

Gore, M. E. .

BRITISH JOURNAL OF CANCER, 2010, 103 (08) :1149-1153

[29] A case of advanced renal cell carcinoma with peritoneal carcinomatosis responding to sorafenib therapy [J].

Akihisa Yao ;

Hideto Iwamoto ;

Shuichi Morizane ;

Tadahiro Isoyama ;

Takehiro Sejima ;

Atsushi Takenaka .

International Cancer Conference Journal, 2012, 1 (4) :198-200

[30] A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma [J].

J M G Larkin ;

T R Ferguson ;

L M Pickering ;

K Edmonds ;

M G James ;

K Thomas ;

U Banerji ;

B Berns ;

C de Boer ;

M E Gore .

British Journal of Cancer, 2010, 103 :1149-1153

← 1 2 3 4 5 →